Biotechnology Assets (STU:041) Cash Flow for Dividends: €0.00 Mil (TTM As of Dec. 2025)


STU:041 Biotechnology Assets SA STU:041
22 GF Score
Price €0.25
GF Value €0.36
! 3 Warning Signs
View Full Analysis

What is Biotechnology Assets Cash Flow for Dividends?

Biotechnology Assets STU:041 22 Cash Flow for Dividends is €0.00 Mil as of Dec. 2025. GuruFocus rates STU:041 with a GF Score™ of 22/100 and a GF Value™ of €0.36. The stock has 3 warning signs investors should review.

Biotechnology Assets's cash flow for dividends for the six months ended in Dec. 2025 was €0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Biotechnology Assets Cash Flow for Dividends Related Terms

Biotechnology Assets Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Biotechnology Assets's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotechnology Assets Cash Flow for Dividends Chart

Biotechnology Assets Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Biotechnology Assets Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:041
22GF Score
Biotechnology Assets SA STU:041
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biotechnology Assets Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of €0.00 Mil mean?
Biotechnology Assets (STU:041) has a Cash Flow for Dividends of €0.00 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Biotechnology Assets and its competitors.
Is Biotechnology Assets' Cash Flow for Dividends too high?
Biotechnology Assets' current Cash Flow for Dividends is €0.00 Mil. Overall, Biotechnology Assets has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Biotechnology Assets' Cash Flow for Dividends compare to VRTX and REGN?
Biotechnology Assets' Cash Flow for Dividends of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Biotechnology company?
A good Cash Flow for Dividends depends on the Biotechnology industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Biotechnology Assets and its competitors. Biotechnology Assets's current Cash Flow for Dividends is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotechnology Assets stock overvalued right now?
Biotechnology Assets (STU:041) has a current Cash Flow for Dividends of €0.00 Mil. The stock's GF Value™ is €0.36, compared to a current price of €0.25 — trading 29.7% below its estimated fair value. The current Cash Flow for Dividends is €0.00 Mil. Biotechnology Assets' overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Biotechnology Assets (STU:041), the current Cash Flow for Dividends is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biotechnology Assets (STU:041) Overvalued in 2026?

Based on GuruFocus' analysis, Biotechnology Assets stock appears to be undervalued. The current stock price of €0.25 is trading 29.7% below its estimated GF Value™ of €0.36.

Key valuation signals for STU:041:

  • Cash Flow for Dividends: €0.00 Mil
  • GF Value™: €0.36 vs. price of €0.25 (29.7% below fair value)
  • GF Score™: 22/100 with 3 warning signs

No single metric tells the full story. See the STU:041 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biotechnology Assets Business Description

Other Exchanges BST:Spain
Address Avenida del Desarrollo Tecnologico, No. 11, Scientific and Technological Park, Jerez de la Frontera, ESP, 11591
Biotechnology Assets SA is a clinical-stage biopharmaceutical company developing and producing biological products for the pharmaceutical and veterinarian sectors. It specializes in the prevention and treatment of niche diseases, such as orphan disease, antigens for new-generation vaccines, feed additives, and probiotics. Adl Bionatur offers a portfolio of non-therapeutic and therapeutic products to tier 1 and tier 2 animal health companies. The company's pipeline products include BNT006, BNT007, BNT010, and others.
22GF Score

Get the complete analysis for STU:041

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.25
Price
€0.36
GF Value